首页> 外文期刊>International Journal of Surgery Case Reports >Hemangiopericytoma/solitary fibrous tumor of the greater omentum: A case report and review of the literature
【24h】

Hemangiopericytoma/solitary fibrous tumor of the greater omentum: A case report and review of the literature

机译:大网膜血管周细胞瘤/孤立性纤维瘤:一例报道并文献复习

获取原文
获取外文期刊封面目录资料

摘要

Introduction: Hemangiopericytoma (HPC) has been first described in 1942 by Stout as a tumor originating from the capillary surrounding pericytes. It is known to occur in any anatomical site, especially the extremities and retroperitoneum. Presentation of case: We describe a case of a 24year old patient presenting with lower abdominal pain due to a tumor of the greater omentum, the patient was treated by conventional laparotomy with tumor resection and the histological evaluation confirmed the diagnosis Hemangiopericytoma/Solitary fibrous tumor (HPC/SFT). The patient has regularly followed-up with periodic imaging for the last 4 years, with no recurrences. Discussion and conclusion: According to our knowledge, HPC rarely develops in the greater omentum, only 20 cases were described in the literature. Primary surgical resection is the treatment of choice. There is no benefit of radiation or systemic chemotherapy. Angiogenic inhibitors represent promising systemic therapeutic concepts.
机译:简介:血管内皮细胞瘤(HPC)在1942年由Stout首次描述为起源于周细胞周围毛细血管的肿瘤。已知它发生在任何解剖部位,特别是四肢和腹膜后。病例介绍:我们描述了一个因大网膜肿瘤而导致下腹部疼痛的24岁患者的病例,该患者接受了常规的剖腹手术并进行了肿瘤切除术,并且组织学评估证实了诊断为血管周皮细胞瘤/孤立性纤维瘤( HPC / SFT)。该患者在过去的4年中定期进行了定期影像学随访,无复发。讨论与结论:据我们所知,大网膜很少发生HPC,文献中仅描述了20例。首选手术切除是治疗的选择。放疗或全身化疗均无益处。血管生成抑制剂代表有希望的全身治疗概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号